Private label makers of anti-bacterial creams and ointments say their products continue to experience growth in an otherwise flat economy — and the statistics back them up.
Data from SymphonyIRI Group, a Chicago-based market research firm, for the 52 weeks ending June 13, show sales growth of just less than 1 percent for all first aid ointments and antiseptics, as compared with 3.4 percent for private label, which reached approximately $207 million
Average price per unit rose 2 cents for the entire subcategory and 3 cents for private label.